A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells

International Journal of Cancer

Volumn 138, Issue 12, 2016, Pages 2894-2904

  Hvichia, G E ^a   Parveen, Z ^a   Wagner, C ^a   Janning, M ^b   Quidde, J ^b   Stein, A ^b   Muller V ^b   Loges, S ^b   Neves, R P L ^c   Stoecklein, N H ^c   Wikman, H ^b   Riethdorf, S ^b   Pantel, K ^b   Gorges, T M ^b  

^a ANGLE North America Inc   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

circulating tumor cell; deformability; epithelial mesenchymal transition; liquid biopsy

Indexed keywords

MESSENGER RNA;

ARTICLE; BIOPSY TECHNIQUE; BLOOD SAMPLING; CELL ASSAY; CELL FUNCTION; CELL ISOLATION; CELL SEPARATION; CELL SEPARATION SYSTEM; CELL SIZE; CELL VIABILITY; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DEVICE; METASTASIS POTENTIAL; MICROFLUIDIC ANALYSIS; MICROFLUIDICS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RNA ANALYSIS; CELL SHAPE; CELL SURVIVAL; DEVICES; LAB ON A CHIP; TUMOR CELL LINE; TUMOR EMBOLISM;

CELL LINE, TUMOR; CELL SEPARATION; CELL SHAPE; CELL SIZE; CELL SURVIVAL; HUMANS; LAB-ON-A-CHIP DEVICES; NEOPLASTIC CELLS, CIRCULATING;

EID: 84962907374     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30007     Document Type: Article

References (37)

1. Ashworth TR., A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust Med J 1869; 14: 146-9.
2. Alix-Panabières C, Pantel K., Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013; 59: 110-8.
3. Alix-Panabières C, Schwarzenbach H, Pantel K., Circulating Tumor Cells and Circulating Tumor DNA. Annu. Rev. Med 2012; 63: 199-215.
4. Yu M, Stott S, Toner M, et al., Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011; 192: 373-82.
5. Gorges TM, Pantel K., Circulating tumor cells as therapy-related biomarkers in cancer patients. Cancer Immunol Immunother 2013; 62: 931-9.
6. Parkinson DR, Dracopoli N, Gumbs Petty B, et al., Considerations in the development of circulating tumor cell technology for clinical use. J Transl Med 2012; 10: 138.
7. Bidard F-C, Peeters DJ, Fehm T, et al., Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 2014; 15: 406-14.
8. Cohen SJ, Punt CJA, Iannotti N, et al., Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26: 3213-21.
9. de Bono JS, Scher HI, Montgomery RB, et al., Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008; 14: 6302-9.
10. Rack B, Schindlbeck C, Jückstock J, et al., Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. J Natl Cancer Inst 2014; 106
11. Cristofanilli M, Budd G., Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Engl J 2004; 781-91.
12. Hou JM, Krebs MG, Lancashire L, et al., Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 2012; 30: 525-32.
13. Guetta E, Gutstein-Abo L, Barkai G., Trophoblasts isolated from the maternal circulation: in vitro expansion and potential application in non-invasive prenatal diagnosis. J Histochem Cytochem 2005; 53: 337-9.
14. Ozkumur E, Shah AM, Ciciliano JC, et al., Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med 2013; 5: 179ra47
15. Vona G, Beroud C, Benachi A, et al., Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood. Am J Pathol 2002; 160: 51-8.
16. Maheswaran S, Sequist LV, Nagrath S, et al., Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008; 359: 366-77.
17. Nagrath S, Sequist LV, Maheswaran S, et al., Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007; 450: 1235-9.
18. Harb W, Fan A, Tran T, et al., Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay. Transl Oncol 2013; 6: 528-38.
19. Kasimir-Bauer S, Hoffmann O, Wallwiener D, et al., Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res 2012; 14: R15
20. Pratt ED, Huang C, Hawkins BG, et al., Rare cell capture in microfluidic devices. Chem Eng Sci 2011; 66: 1508-22.
21. Desitter I, Guerrouahen BS, Benali-furet N, et al., A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res 2011; 31: 427-41.
22. Wilding P, Kricka LJ, Cheng J, et al., Integrated cell isolation and polymerase chain reaction analysis using silicon microfilter chambers. Anal Biochem 1998; 257: 95-100.
23. Möhlendick B, Bartenhagen C, Behrens B, et al., A robust method to analyze copy number alterations of less than 100 kb in single cells using oligonucleotide array CGH. PLoS One 2013; 8
24. Mohlendick B, Stoecklein NH., Analysis of copy-number alterations in single cells using microarray-based comparative genomic hybridization (aCGH). Curr Protoc Cell Biol 2014; 65: 21-2.
25. Baudis M, Cleary ML., Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 2001; 17: 1228-9.
26. Neves RPL, Raba K, Schmidt O, et al., Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer. Clin Chem 2014; 60: 1290-7.
27. Sieuwerts AM, Kraan J, Bolt J, et al., Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009; 101: 61-6.
28. Vona G, Sabile A, Louha M, et al., Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 2000; 156: 57-63.
29. Harouaka R, Nisic M, Zheng S., Circulating tumor cell enrichment based on physical properties. J Lab Autom 2013; 18: 1-24.
30. Mohamed H, Murray M, Turner JN, et al., Isolation of tumor cells using size and deformation. J Chromatogr A 2009; 1216: 8289-95.
31. Zheng Y, Wen J, Nguyen J, et al., Decreased deformability of lymphocytes in chronic lymphocytic leukemia. Sci Rep 2015; 5: 7613.
32. Karabacak NM, Spuhler PS, Fachin F, et al., Microfluidic, marker-free isolation of circulating tumor cells from blood samples. Nat Protoc 2014; 9: 694-710.
33. Baccelli I, Schneeweiss A, Riethdorf S, et al., Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 2013; 31: 539-44.
34. Hodgkinson CL, Morrow CJ, Li Y, et al., Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 2014; 20: 897-903.
35. Heitzer E, Auer M, Gasch C, et al., Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res [Internet] 2013; 73: 2965-75.
36. Gasch C, Bauernhofer T, Pichler M, et al., Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin Chem 2013; 59: 252-60.
37. Obermayr E, Maritschnegg E, Speiser P, Singer C, Schuster E, Holzer B, Danzinger S, Pecha N, Newland A, O'Brian M, Zeillinger R,. Circulating rare cells enable highly efficient cancer detection. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research. Philadelphia, PA: AACR, 2015.